NCT07609550 Feasibility and Implementation of Early Referral in Perinatal Mental Health
| NCT ID | NCT07609550 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Seville |
| Condition | Perinatal Depression |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2026-07-15 |
| Primary Completion | 2027-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,000 participants in total. It began in 2026-07-15 with a primary completion date of 2027-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is part of the e-Perinatal project and is embedded within the main cluster randomized trial. The primary aim is to evaluate the feasibility, acceptability, and preliminary effectiveness of an early diagnosis detection and referral strategy to specialized mental health services within routine maternal care. The secondary aim is to validate and implement an Artificial Intelligence-based algorithm for the early screening of mental health disorders in routine services.
Eligibility Criteria
Inclusion Criteria: * Pregnant and postpartum women enrolled in the main e-Perinatal trial, indicating the presence of a depressive or anxiety disorder with CIDI. * Access to smartphone and internet * Able to write and read in Spanish Exclusion Criteria: * None beyond those defined in the main trial
Contact & Investigator
Emma Motrico, PhD
PRINCIPAL INVESTIGATOR
University of Seville
Frequently Asked Questions
Who can join the NCT07609550 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Perinatal Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07609550 currently recruiting?
Yes, NCT07609550 is actively recruiting participants. Contact the research team at eperinatal@us.es for enrollment information.
Where is the NCT07609550 trial being conducted?
This trial is being conducted at Mairena del Aljarafe, Spain.
Who is sponsoring the NCT07609550 clinical trial?
NCT07609550 is sponsored by University of Seville. The principal investigator is Emma Motrico, PhD at University of Seville. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.